A Clinical Analysis of Extrapulmonary Complications in Novel Coronavirus Pneumonia Patients

Abstract

Bo-Wen Sun,1,* Min Zhang,1,* Ping-Chao Wang,2 Jiang-Tao Song3 1Department of Respiratory Medicine, Heilongjiang Provincial Hospital, Harbin Institute of Technology, Harbin, 150036, People’s Republic of China; 2Department of Critical Care Medicine, People’s Hospital of Hanchuan, Hanchuan, 431600, People’s Republic of China; 3Department of Orthopedics, People’s Hospital of Hanchuan, Hanchuan, 431600, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ping-Chao WangDepartment of Critical Care Medicine, People’s Hospital of Hanchuan, No. 1 Of Peoples Avenue, Hanchuan, 431600, People’s Republic of ChinaTel [phone]Email [email protected] SongDepartment of Orthopedics, People’s Hospital of Hanchuan, No. 1 Of Peoples Avenue, Hanchuan, 431600, People’s Republic of ChinaTel [phone]Email [email protected]: This study aimed to investigate the clinical manifestation and treatment effects of extrapulmonary complications in cases of novel coronavirus pneumonia.Methods: The clinical data of patients with novel coronavirus pneumonia who were admitted to Hanchuan People’s Hospital between January and March 2020 were retrospectively analyzed, and the clinical characteristics, laboratory test results, and treatment pathways of patients with extrapulmonary complications were analyzed and summarized.Results: Of the 500 patients in this study, 97 patients with a history of chronic diseases were excluded, and 152 patients had extrapulmonary complications. Common extrapulmonary syndromes: 98 patients (64.47%) suffered from digestive system involvement; 43 patients (28.29%) suffered from cardiovascular system damage; 32 patients (21.05%) had urinary system damage; 25 patients (16.45%) had nervous system damage; and 30 patients (19.74%) had more than two kinds of system damage. In all cases, these patients were treated with comprehensive measures, and effective outcomes were achieved.Conclusion: According to the clinical characteristics and laboratory test results of this sample group, early evaluation of patients with extrapulmonary complications and timely symptomatic treatment can effectively improve outcomes of pneumonia treatment, accelerate the alleviation of symptoms, and improve patients’ condition.Keywords: novel coronavirus pneumonia, clinical characteristics, laboratory test, extrapulmonary complications, curative effect

Keywords

• novel coronavirus pneumonia
• clinical characteristics
• laboratory test
• extrapulmonary complications
• curative effect.